SUN1 interacts with nuclear lamin A and cytoplasmic nesprins to provide a physical connection between the nuclear lamina and the cytoskeletonMOLECULAR AND CELLULAR BIOLOGYIF2.72023-03-27493OAAI
GIPR gene expression in testis is mouse specific and can impact male mouse fertilityANDROLOGYIF3.42022-03-083PRE
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeysCELL REPORTS MEDICINEIF10.62021-05-0154OAAI
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonismNATURE COMMUNICATIONSIF15.72020-10-0578OAAI
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptorMABSIF7.32020-01-127OAAI
Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical modelsSCIENCE TRANSLATIONAL MEDICINEIF14.62018-12-19157OAAI
Haploinsufficiency of the Insulin Receptor in the Presence of a Splice-Site Mutation in Ppp2r2a Results in a Novel Digenic Mouse Model of Type 2 DiabetesDIABETESIF7.52016-02-1122OAAI
Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N → S (nN → σ*S-X) Interaction for Conformational ConstraintJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-12-0136OAAI
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational AnalysisJOURNAL OF MEDICINAL CHEMISTRYIF6.82015-06-0125PREAI
A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in miceLIPIDS IN HEALTH AND DISEASEIF4.22014-10-3113OAAI
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 4. Exploration of a Novel Binding PocketJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-07-0813PREAI
Small Molecule Disruptors of the Glucokinase Glucokinase Regulatory Protein Interaction: 3. Structure Activity Relationships within the Aryl Carbinol Region of the N-Arylsulfonamido-N'-arylpiperazine SeriesJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-03-3155PREAI
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-Concept (vol 57, pg 309, 2014)JOURNAL OF MEDICINAL CHEMISTRYIF6.82014-02-280PREAI
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 2. Leveraging Structure-Based Drug Design to Identify Analogues with Improved Pharmacokinetic ProfilesJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-01-0922PREAI
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 1. Discovery of a Novel Tool Compound for in Vivo Proof-of-ConceptJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-01-0936PREAI
Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese MiceJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82011-07-0132PREAI
New Variants in the Enpp1 and Ptpn6 Genes Cause Low BMD, Crystal-Related Arthropathy, and Vascular CalcificationJOURNAL OF BONE AND MINERAL RESEARCHIF5.92009-12-0439OAAI
A Point Mutation in Sec61α1 Leads to Diabetes and Hepatosteatosis in MiceDIABETESIF7.52009-11-2362OAAI
Antidiabetic effects of 11β-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosisDIABETES OBESITY & METABOLISMIF5.72009-05-2827PREAI
Identification of three loci affecting HDL-cholesterol levels in a screen for chemically induced recessive mutations in miceJOURNAL OF LIPID RESEARCHIF4.12009-03-015OAAI